Abstract
Thyroid dysfunction and psychiatric disorders share a bidirectional relation. Thyroid hormones have been found to affect the central nervous system both structurally and functionally. Conventional antidepressant drug therapy is characterized by a delayed and at times suboptimal response. Various strategies have been devised in order to circumvent this limitation. L- Thyroxine has been used as both acceleration therapy and augmentation therapy as adjuvant therapy with antidepressants. The hormone has also been used as monotherapy, both in prevention and management of depression. The potential use of thyroid hormone as an adjunct therapy in management of euthyroid depression and relevant patents has been discussed.
Keywords: Antidepressant, depression, endocrinology, psychiatry, thyroid, thyroxine.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Euthyroid Depression: The Role of Thyroid Hormone
Volume: 8 Issue: 1
Author(s): Sanjay Kalra and Yatan Pal Singh Balhara
Affiliation:
Keywords: Antidepressant, depression, endocrinology, psychiatry, thyroid, thyroxine.
Abstract: Thyroid dysfunction and psychiatric disorders share a bidirectional relation. Thyroid hormones have been found to affect the central nervous system both structurally and functionally. Conventional antidepressant drug therapy is characterized by a delayed and at times suboptimal response. Various strategies have been devised in order to circumvent this limitation. L- Thyroxine has been used as both acceleration therapy and augmentation therapy as adjuvant therapy with antidepressants. The hormone has also been used as monotherapy, both in prevention and management of depression. The potential use of thyroid hormone as an adjunct therapy in management of euthyroid depression and relevant patents has been discussed.
Export Options
About this article
Cite this article as:
Kalra Sanjay and Singh Balhara Pal Yatan, Euthyroid Depression: The Role of Thyroid Hormone, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2014; 8 (1) . https://dx.doi.org/10.2174/1872214807666131229130540
DOI https://dx.doi.org/10.2174/1872214807666131229130540 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Biology of Cox-2: An Application in Cancer Therapeutics
Current Drug Targets Early Detection of Epileptic Seizures in Sparse Domains
Neuroscience and Biomedical Engineering (Discontinued) Protein/Polyphenol Interactions: Past and Present Contributions. Mechanisms of Astringency Perception
Current Organic Chemistry Meet Our Regional Editor
Current Bioinformatics Peptide Activators of the p53 Tumor Suppressor
Current Pharmaceutical Design Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders
CNS & Neurological Disorders - Drug Targets Regulation of UDP Glucuronosyltransferase Genes
Current Drug Metabolism The SNPs within 3'UTR of miRNA Target Genes Related to Multiple Sclerosis: A Computational Prediction
Current Pharmacogenomics and Personalized Medicine Cognitive Behavioral Approaches for Treating Suicidal Behavior in Adolescents
Current Psychiatry Reviews Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease
CNS & Neurological Disorders - Drug Targets It is Now Personal: Recent Views on the Assessment of Therapeutic Infidelity in Severe Mental Illness
Current Clinical Pharmacology Restoration of the Striatal Dopamine Synthesis for Parkinsons Disease:Viral Vector-Mediated Enzyme Replacement Strategy
Current Gene Therapy Synthesis of Biologically Active Selenium-Containing Molecules From Greener Perspectives
Current Green Chemistry Targeting Extracellular Matrix Proteolysis for Hemorrhagic Complications of tPA Stroke Therapy
CNS & Neurological Disorders - Drug Targets Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery
Pharmaceutical Nanotechnology Scientific Basis for the Use of Indian Ayurvedic Medicinal Plants in the Treatment of Neurodegenerative Disorders: 1. Ashwagandha
Central Nervous System Agents in Medicinal Chemistry Pharmacologic Overview of Chlorogenic Acid and its Metabolites in Chronic Pain and Inflammation
Current Neuropharmacology Nanomaterials for Improving the Properties of Polymeric Electrolyte Membranes in Energy Managing Devices
Nanoscience & Nanotechnology-Asia Tachykinins and Neuropsychiatric Disorders
Current Drug Targets Cordycepin Exerts Neuroprotective Effects via an Anti-Apoptotic Mechanism based on the Mitochondrial Pathway in a Rotenone-Induced Parkinsonism Rat Model
CNS & Neurological Disorders - Drug Targets